BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16715497)

  • 1. Homologous down-regulation of histamine H3 receptors in rat striatal slices.
    Garduño-Torres B; Arias-Montaño JA
    Synapse; 2006 Aug; 60(2):165-71. PubMed ID: 16715497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices.
    Sánchez-Lemus E; Arias-Montaño JA
    Neurosci Lett; 2004 Jul; 364(3):179-84. PubMed ID: 15196671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex.
    Alves-Rodrigues A; Leurs R; Wu TS; Prell GD; Foged C; Timmerman H
    Br J Pharmacol; 1996 Aug; 118(8):2045-52. PubMed ID: 8864541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
    Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
    Garbarg M; Arrang JM; Rouleau A; Ligneau X; Tuong MD; Schwartz JC; Ganellin CR
    J Pharmacol Exp Ther; 1992 Oct; 263(1):304-10. PubMed ID: 1383495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-synaptic histamine H3 receptors regulate glutamate, but not GABA release in rat thalamus.
    Garduño-Torres B; Treviño M; Gutiérrez R; Arias-Montaño JA
    Neuropharmacology; 2007 Feb; 52(2):527-35. PubMed ID: 17027043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous desensitization of human histamine H₃ receptors expressed in CHO-K1 cells.
    Osorio-Espinoza A; Escamilla-Sánchez J; Aquino-Jarquin G; Arias-Montaño JA
    Neuropharmacology; 2014 Feb; 77():387-97. PubMed ID: 24161268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
    Witte DG; Yao BB; Miller TR; Carr TL; Cassar S; Sharma R; Faghih R; Surber BW; Esbenshade TA; Hancock AA; Krueger KM
    Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
    Dai H; Fu Q; Shen Y; Hu W; Zhang Z; Timmerman H; Leurs R; Chen Z
    Eur J Pharmacol; 2007 Jun; 563(1-3):117-23. PubMed ID: 17350613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different role of cAMP dependent protein kinase and CaMKII in H3 receptor regulation of histamine synthesis and release.
    Moreno-Delgado D; Gómez-Ramírez J; Torrent-Moreno A; González-Sepúlveda M; Blanco I; Ortiz J
    Neuroscience; 2009 Dec; 164(3):1244-51. PubMed ID: 19735700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
    Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.
    Kitbunnadaj R; Hashimoto T; Poli E; Zuiderveld OP; Menozzi A; Hidaka R; de Esch IJ; Bakker RA; Menge WM; Yamatodani A; Coruzzi G; Timmerman H; Leurs R
    J Med Chem; 2005 Mar; 48(6):2100-7. PubMed ID: 15771452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions.
    Humbert-Claude M; Morisset S; Gbahou F; Arrang JM
    Biochem Pharmacol; 2007 Apr; 73(8):1172-81. PubMed ID: 17306767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D(1) receptor facilitation of depolarization-induced release of gamma-amino-butyric acid in rat striatum is mediated by the cAMP/PKA pathway and involves P/Q-type calcium channels.
    Arias-Montaño JA; Floran B; Floran L; Aceves J; Young JM
    Synapse; 2007 May; 61(5):310-9. PubMed ID: 17318879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.
    Kitbunnadaj R; Zuiderveld OP; De Esch IJ; Vollinga RC; Bakker R; Lutz M; Spek AL; Cavoy E; Deltent MF; Menge WM; Timmerman H; Leurs R
    J Med Chem; 2003 Dec; 46(25):5445-57. PubMed ID: 14640553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.
    Kovalainen JT; Christiaans JA; Kotisaari S; Laitinen JT; Männistö PT; Tuomisto L; Gynther J
    J Med Chem; 1999 Apr; 42(7):1193-202. PubMed ID: 10197963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine protects against NMDA-induced necrosis in cultured cortical neurons through H receptor/cyclic AMP/protein kinase A and H receptor/GABA release pathways.
    Dai H; Zhang Z; Zhu Y; Shen Y; Hu W; Huang Y; Luo J; Timmerman H; Leurs R; Chen Z
    J Neurochem; 2006 Mar; 96(5):1390-400. PubMed ID: 16478529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of chemical and low-intensity mechanical nociception by activation of histamine H3 receptors.
    Cannon KE; Hough LB
    J Pain; 2005 Mar; 6(3):193-200. PubMed ID: 15772913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.